Document ID: chunk:federal_register_of_legislation:F2023L01164:reg:9
Version: federal_register_of_legislation:F2023L01164
Segment Type: reg
Provision Reference: reg 9
Character Range: 3800–4893

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting Charcot-Marie-Tooth disease or death from Charcot-Marie-Tooth disease with the circumstances of a person's relevant service:
(1)          taking a drug that cannot be ceased or substituted in the long term and which is associated in the individual with the clinical worsening of Charcot-Marie-Tooth disease during drug therapy and either:
             (a)          the improvement of Charcot-Marie-Tooth disease within 3 months of discontinuing or tapering drug therapy; or
             (b)          the clinical worsening of Charcot-Marie-Tooth disease on rechallenge with the same drug or another drug from the same class of drugs; and
where the drug was being taken at the time of the clinical worsening of Charcot-Marie-Tooth disease;
(2)                         inability to obtain appropriate clinical management for Charcot-Marie-Tooth disease before the clinical worsening of Charcot-Marie-Tooth disease.